Examination of HCV infection in hemodialysis patients with HCV-RNA assay using a magnetic extraction method (AmpliCap GT HCV MONITOR Test Kit v2.0 and AmpliCap GT HCV Specimen Preparation Kit v2.0)

Japanese Journal of Nephrology

Volumn 45, Issue 2, 2003, Pages 91-97

  Tanaka, Motoko ^a   Fujiyama, Shigetoshi ^b   Tanaka, Motohiko ^h   Itoh, Kazuko ^a   Matsushita, Kazutaka ^h   Hara, Michiaki ^c   Kuwahara, Kuniharu ^d   Yasumoto, Naruhiro ^e   Nishimura, Yasuhiro ^f   Yoshimura, Nobuaki ^g   Tomita, Kimio ^b  

^a Akebono Clinic   (Japan)

^b KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

^c Hara Clinic   (Japan)

^d Kuwahara Clinic   (Japan)

^e Yasumoto Medical Clinic   (Japan)

^f Yatsushiro General Hospital   (Japan)

^g Kikuchi Medical Association Hospital   (Japan)

^h NONE

Author keywords

HCV RNA; Hepatitis C virus(HCV) infection; Magnetic extraction method; Polymerase chain reaction(PCR) assayhemodialysis(HD)

Indexed keywords

ERYTHROPOIETIN; HEPARIN; INTERFERON; VIRUS RNA;

ANEMIA; ARTICLE; BLOOD DONOR; BLOOD TRANSFUSION; DIAGNOSTIC KIT; DIAGNOSTIC VALUE; ENVIRONMENTAL PROTECTION; EXTRACTION; GENOTYPE; HEMODIALYSIS; HEPATITIS C; HEPATITIS C VIRUS; HIGH RISK POPULATION; HOSPITAL INFECTION; HUMAN; INFECTION RISK; INTERMETHOD COMPARISON; MAGNETISM; POLYMERASE CHAIN REACTION; PROGNOSIS; SAFETY; SCREENING; VIRUS LOAD;

AGED; BIOLOGICAL MARKERS; FEMALE; GENOTYPE; HEPACIVIRUS; HEPATITIS C; HUMANS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; RENAL DIALYSIS; RISK; RNA, VIRAL; TIME FACTORS;

EID: 0345373934     PISSN: 03852385     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Chan TM, Wu PC, Lau JYN, Lok ASF, Lai CL, Cheng IKP. Interferon treatment for hepatitis C virus infection in patients on hemodialysis. Nephrol Dial Transplant 1997; 12: 1414-9.
2. Okuda K, Hayashi H, Yokozeki K, et al. Interferon treatment for chronic hepatitis C in haemodialysis patients: Suggestions based on small series, J Gastroenterol Hepatol 1995; 10: 616-20.
3. Pol S, Thiers V, Carnot F, Zins B, Romeo R, Berthelot P, Brechot C. Efficacy and tolerance of α-2b interferon therapy on HCV infection of hemodialyzed patients. Kiney Int 1995; 47: 1412-8.
4. Miyachi H, Masukawa A, Ohshima T, Hirose T, Impraim C, Ando Y. Automated specific capture of hepatic C virus RNA with probes and paramagnetic particle separation: J Clin Microbiol 2000; 38: 18-21.
5. Tanaka M, Fujiyama S, Tanaka M, Itoh K, Matsushita K, Matsuyama K, Kakuda H, Tomita K. Clinical usefulness of a new hepatitis C virus RNA extraction method using specific capture probe and magnetic particle in hemodialysis patients. Nephrol Dial Transplant 2002; 17(Suppl): 108.
6. Kobayashi M, Tanaka E, Oguchi H, Hara K, Kiyosawa K. Prospective follow-up study of hepatitis C virus infection in patients undergoing maintenance hemodialysis: comparison among hemodialysis units. J Gastroenterol Hepatol 1998; 13: 604-9.
7. Caramrlo C, Navas S, Alberola ML, et al. Evidence against transmission of hepatitis C virus through hemodialysis ultrafiltrate and peritoneal fluid. Nephron 1994; 66: 470-3.
8. Ono K, Ono T, Matsumata T. The pathogenesis of decreased aminotransferase and alanine aminotransferase activity in the plasma of hemodialysis patients; the role of vitamin B6 deficiency. Clin Nephrol 1995; 43: 405-8.
9. Furusho N, Hayashi J, Ariyama I, Sawayama Y, Etoh Y, Shigematsu M, Kashiwagi S. Maintenance hemodialysis decreases serum hepatitis C virus(HCV)RNA levels in hemodialysis patients with chronic HCV infection. Am J Gastroenterol 2000; 95: 490-6.
10. Puoti M, Sandrini S, Zaltron S. Impact of hepatitis C virus infection on patients with chronic renal failure. J Nephrol 1995; 8: 291-9.
11. Schneeberger PM, Keur I, van der Vliet W, van Hoek K, Boswijk H, van Loon AM, van Dijk WC, Kauffmann RH, Quint W, van Doorn LJ. Hepatitis C virus infections in dialysis centers in The Netherlands: a national survey by serological and molecular methods. J Clin Microbiol 1998; 36: 1711-5.
12. Casanovas TT, Baliellas C, Sese E, Iborra MJ, Benasco C, Andres L, Gonzalez MT, Gil-Vermet S, Casanova A, Casals LA. Interferon may be useful in hemodialysis patients with HCV chronic infection who are candidates to kidney transplant. Hepatology 1994; 20: 337A.